CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis

Ähnliche Einträge

• Cost‐effectiveness of subcutaneous immunotherapy for house dust mite‐induced allergic rhinitis in China
  von: Lei Ren, et al.
  Veröffentlicht: (2025)
• Immune signatures predict response to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis
  von: Nan Wang, et al.
  Veröffentlicht: (2024)
• Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real‐life, multi‐center study
  von: Qingxiu Xu, et al.
  Veröffentlicht: (2024)
• Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1–4 years old children with perennial allergic rhinitis
  von: Koki Sasamoto, et al.
  Veröffentlicht: (2024)
• Editorial comment on “Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1–4 years old children with perennial allergic rhinitis”
  von: Umit Murat Sahiner, et al.
  Veröffentlicht: (2024)